Erectile Dysfunction Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Erectile Dysfunction stocks.

Erectile Dysfunction Stocks Recent News

Date Stock Title
May 5 LLY 3 Super-Safe Dividend Stocks That Have Been Making Recurring Payments for 130+ Years
May 5 LLY 3 No-Brainer Stocks to Buy in May
May 4 LLY Pharma R&D productivity seen improving for the first time in years - Deloitte
May 4 PFE Pharma R&D productivity seen improving for the first time in years - Deloitte
May 4 LLY Eli Lilly: Great Time To Divest Before It Potentially Crashes
May 4 PFE Do These 3 Checks Before Buying Pfizer Inc. (NYSE:PFE) For Its Upcoming Dividend
May 4 LLY Move Over, Mounjaro. Eli Lilly Has Another Blockbuster in the Making
May 4 LLY Can Pfizer Challenge Lilly and Novo Nordisk in the Obesity Market?
May 4 PFE Can Pfizer Challenge Lilly and Novo Nordisk in the Obesity Market?
May 4 LLY Eli Lilly Raised Its Outlook. Is the Stock a Buy Now?
May 4 PFE 3 High-Yield Dividend Stocks to Buy Now and Hold at Least a Decade
May 3 LLY Amazon Stock Is on a Roll. Here’s Why It’s on This Firm’s ‘Best Ideas List.’
May 3 LLY Amgen's peek at its GLP-1 drug trial results heightens competition in obesity market
May 3 PFE Amgen's peek at its GLP-1 drug trial results heightens competition in obesity market
May 3 LLY Eli Lilly Remains Expensive Here - Minimal Margin Of Safety
May 3 LLY Analyst unveils Amgen stock price target after weight-loss drug data
May 3 PFE Vanguard Health Care Fund's Strategic Moves in Q1 2024: A Focus on Pfizer Inc
May 3 LLY Amgen (AMGN) Q1 Earnings Top, Stock Up on Obesity Drug Update
May 3 LLY Weight-loss drug competition heats up. Is Wegovy in trouble?
May 3 LLY Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims
Erectile Dysfunction

Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.
A physical cause can be identified in about 80% of cases. These include cardiovascular disease, diabetes mellitus, neurological problems such as following prostatectomy, hypogonadism, and drug side effects. Psychological impotence is where erection or penetration fails due to thoughts or feelings; this is somewhat less frequent, in the order of about 10% of cases. In psychological impotence, there is a strong response to placebo treatment.
Treatment involves addressing the underlying causes, lifestyle modifications, and addressing psychosocial issues. In many cases, a trial of pharmacological therapy with a PDE5 inhibitor, such as sildenafil, can be attempted. In some cases, treatment can involve inserting prostaglandin tablets into the urethra, injecting smooth muscle relaxants and vasodilators into the penis, a penile prosthesis, a penis pump, or vascular reconstructive surgery. It is the most common sexual problem in men.

Browse All Tags